These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6197496)

  • 1. Mechanism of action of metronidazole on Bacteroides fragilis.
    Sigeti JS; Guiney DG; Davis CE
    J Infect Dis; 1983 Dec; 148(6):1083-9. PubMed ID: 6197496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal antimicrobial synergism between Escherichia coli and Bacteroides fragilis in the presence of metronidazole.
    Soriano F; Ponte MC; Gaspar MC
    J Clin Pathol; 1982 Oct; 35(10):1150-2. PubMed ID: 6752209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oxygen and UV irradiation on nucleic acid and protein syntheses in Bacteroides fragilis.
    Schumann JP; Jones DT; Woods DR
    J Bacteriol; 1983 Dec; 156(3):1366-8. PubMed ID: 6196352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning of Bacteroides fragilis plasmid genes affecting metronidazole resistance and ultraviolet survival in Escherichia coli.
    Wehnert GU; Abratt VR; Goodman HJ; Woods DR
    Plasmid; 1990 Mar; 23(2):155-8. PubMed ID: 2194230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of a gene from Bacteroides fragilis involved in metronidazole resistance in Escherichia coli.
    Wehnert GU; Abratt VR; Woods DR
    Plasmid; 1992 May; 27(3):242-5. PubMed ID: 1513881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of cefuroxime and cefotaxime by Bacteroides fragilis in vitro, and its influence on the treatment of an experimental Escherichia coli/Bacteroides fragilis mixed infection.
    Beale AS; Gisby J
    J Antimicrob Chemother; 1989 Jul; 24(1):29-37. PubMed ID: 2674099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of antimicrobial activity of metronidazole in mixed cultures of Bacteroides fragilis and Escherichia coli.
    Moran FJ; Perez C; Hurtado C; Blanco MT; Prieto J
    J Antimicrob Chemother; 1988 Aug; 22(2):261-2. PubMed ID: 3053557
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined activity of metronidazole and gentamicin on Bacteroides fragilis in vivo and in vitro.
    Dijkmans BA; Vaishnav J; Mattie H
    J Antimicrob Chemother; 1985 Jan; 15(1):77-82. PubMed ID: 3882656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of metronidazole on Bacteroides fragilis and/or Escherichia coli in vitro and in vivo.
    Rylander M; Holm SE; Brorson JE; Johnsson J; Norrby R
    J Antimicrob Chemother; 1981 Mar; 7(3):257-67. PubMed ID: 7024242
    [No Abstract]   [Full Text] [Related]  

  • 10. Mode of action of metronidazole and a Bacteroides fragilis metA resistance gene in Escherichia coli.
    Dachs GU; Abratt VR; Woods DR
    J Antimicrob Chemother; 1995 Apr; 35(4):483-96. PubMed ID: 7628983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteroides fragilis RecA protein overexpression causes resistance to metronidazole.
    Steffens LS; Nicholson S; Paul LV; Nord CE; Patrick S; Abratt VR
    Res Microbiol; 2010 Jun; 161(5):346-54. PubMed ID: 20435137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyruvate dehydrogenase activity and metronidazole susceptibility in Bacteroides fragilis.
    Tabaqchali S; Pantosti A; Oldfield S
    J Antimicrob Chemother; 1983 May; 11(5):393-400. PubMed ID: 6874627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in-vitro activity of metronidazole against Enterobacteriaceae alone and in mixed cultures with Bacteroides fragilis.
    Moran FJ; Perez C; Hurtado C; Blanco MT; Prieto J
    J Antimicrob Chemother; 1987 Nov; 20(5):657-61. PubMed ID: 3429370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and mode of action of a bacteriocin produced by a Bacteroides fragilis strain.
    Mossie KG; Jones DT; Robb FT; Woods DR
    Antimicrob Agents Chemother; 1979 Dec; 16(6):724-30. PubMed ID: 93876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial synergy in mixed aerobic/anaerobic infections.
    Ingham HR; Selkon JB; Sisson PR; Middleton RL
    Lancet; 1980 Mar; 1(8169):659-60. PubMed ID: 6102668
    [No Abstract]   [Full Text] [Related]  

  • 16. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
    Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
    Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of metronidazole in mixed cultures.
    Ingham HR; Sisson PR
    J Antimicrob Chemother; 1988 Sep; 22(3):387. PubMed ID: 3053563
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolation and properties of metronidazole-resistant mutants of Bacteroides fragilis.
    Britz ML; Wilkinson RG
    Antimicrob Agents Chemother; 1979 Jul; 16(1):19-27. PubMed ID: 475371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of an amino reduction product of metronidazole in bacterial cultures: lack of bactericidal activity.
    Ehlhardt WJ; Beaulieu BB; Goldman P
    Biochem Pharmacol; 1987 Jan; 36(2):259-64. PubMed ID: 3545214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BmeRABC5 is a multidrug efflux system that can confer metronidazole resistance in Bacteroides fragilis.
    Pumbwe L; Chang A; Smith RL; Wexler HM
    Microb Drug Resist; 2007; 13(2):96-101. PubMed ID: 17650960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.